#United States #Siemens Healthineers #Parsippany #Scopio Labs #digital healthcare

Scopio Labs and Siemens Healthineers Strengthen Their Partnership

In a significant advancement for medical diagnostics, Scopio Labs has recently broadened its strategic partnership with Siemens Healthineers to include the worldwide distribution of its revolutionary Full-Field Bone Marrow Aspirate™ (FF-BMA) Application. This cutting-edge technology marks the dawn of the first digital solution designed specifically for reviewing bone marrow aspirates. With this enhancement, Scopio Labs is striving to simplify and accelerate the analysis process, a crucial improvement for clinical laboratories grappling with staffing shortages and a growing need for efficient diagnostic solutions.

Traditional methods of analyzing bone marrow aspirate, which necessitate trained professionals to scrutinize slides under a microscope, are notoriously labor-intensive and time-consuming. As the healthcare landscape evolves, so does the necessity for innovative solutions that meet the demands of understaffed clinical environments. Scopio Labs' FF-BMA application allows professionals to view results remotely over secured hospital networks, sidestepping the need for manual microscopy. This remote capability enables medical experts to generate diagnoses regardless of their physical location, vastly improving accessibility and efficiency within clinical settings.

Bob Stowers, head of Specialty Lab Solutions at Siemens Healthineers, emphasized the optimism surrounding the integration of technology into laboratory processes. He referenced a survey that highlighted a promising trend among lab professionals: 91% believe that AI and technology can address critical patient care challenges, while 90% assert that adopting such tools is vital for improving patient care. The alliance aims to not only expedite result delivery but also enhance recruitment efforts by attracting new talent eager to engage in advanced testing methodologies.

Scopio's technological offering isn't just about speed; it also comprises sophisticated features designed to enrich laboratory workflows. The FF-BMA solution integrates Full-Field digital imaging at a magnification of 100x, complemented by AI-powered Decision Support, which collectively optimizes lab processes and augments diagnostic confidence. Such advancements allow for the standardization of procedures while facilitating collaboration and second opiniones, a critical component in complex diagnostic evaluations.

“It’s an exciting milestone in our partnership with Siemens Healthineers and a pivotal step toward the digitization of laboratory practices worldwide,” stated Itai Hayut, CEO and Co-Founder of Scopio Labs. He advocates that the FF-BMA application brings remarkable efficiencies and standardizations to hematology practices, revolutionizing how medical professionals engage with laboratory results.

The reciprocally beneficial relationship between Scopio Labs and Siemens Healthineers is already extensive, covering the distribution of Scopio's imaging platforms, including the Full-Field Peripheral Blood Smear (FF-PBS) Application. By infusing their portfolio with this innovative digital solution, Siemens Healthineers is poised to meet the evolving demands of hematology laboratories, ultimately facilitating improved patient outcomes.

As the healthcare sector continues to embrace digitization, tools like Scopio's FF-BMA application represent the future of pathology and hematopathology lab practices. The implications of these advancements are monumental, showcasing a concerted effort within the industry to leverage technology to enhance patient care.

Disclaimer

The availability of Scopio Labs' Full-Field Peripheral Blood Smear™ Application and Full-Field Bone Marrow Aspirate™ Application may vary based on regional regulations.

About Scopio Labs

Scopio Labs is at the forefront of developing full-field digital imaging dedicated to hematology diagnostics. Through its innovative platforms, Scopio empowers laboratory scientists and clinicians with unparalleled digital cell morphology analysis, thereby accelerating the detection of blood-related medical conditions and expediting life-saving treatments for patients. With FDA clearance and CE marking for its platforms, Scopio Labs is redefining how laboratory professionals interpret and act upon critical diagnostic information.